Published in Cancer Weekly, September 19th, 2000
"VEGF is a potent paracrine angiogenic factor involved in angiogenesis," wrote T. Nakashima and colleagues, University of Texas. "We determined whether antisense VEGF transfection can suppress angiogenic activity of a human SCCHN cell line" ("Antisense inhibition of vascular endothelial growth factor in human and neck squamous cell carcinoma," Head and Neck - Journal for the Sciences and Specialties of the Head and Neck, August...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.